Keyphrases
Coumarin
100%
Selective Serotonin Reuptake Inhibitors
100%
Bleeding Risk
100%
Concurrent Use
100%
Confidence Interval
83%
Bleeding
83%
Adjusted Odds Ratio
66%
Gastrointestinal Bleeding
66%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
50%
Hospitalization Risk
50%
Abnormal Bleeding
50%
Odds Ratio
33%
Hereafter
33%
Dutch
16%
Phenprocoumon
16%
Acenocoumarol
16%
Vitamin K Antagonists
16%
Linkage System
16%
Pharmacy
16%
Hospitalization
16%
Control Subjects
16%
New User
16%
Conditional Logistic Regression Analysis
16%
Major Bleeding
16%
Primary Diagnosis
16%
Medicine and Dentistry
Selective Serotonin Reuptake Inhibitor
100%
Bleeding
100%
Coumarin Derivative
100%
Odds Ratio
85%
Gastrointestinal Bleeding
57%
Nonsteroid Antiinflammatory Agent
42%
Logistic Regression Analysis
14%
Gene Linkage
14%
Vitamin K Antagonist
14%
Acenocoumarol
14%
Phenprocoumon
14%
Case-Control Study
14%
Major Bleeding
14%
Coumarin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Coumarin Derivative
100%
Selective Serotonin Reuptake Inhibitor
100%
Bleeding
100%
Gastrointestinal Hemorrhage
50%
Non-Steroidal Anti-Inflammatory Drug
37%
Case-Control Study
12%
Coumarin
12%
Antivitamin K
12%
Acenocoumarol
12%
Phenprocoumon
12%